Immunostimulatory AdCD40L gene therapy combined with low-dose cyclophosphamide in metastatic melanoma patients - Concepedia

Concepedia

Publication | Open Access

Immunostimulatory AdCD40L gene therapy combined with low-dose cyclophosphamide in metastatic melanoma patients

DOI Full Paper Access

46

Citations

11

References

2016

Year

Angelica Loskog, Aglaia Maleka, Sara M. Mangsbo, Emma Svensson, C. Lundberg, Anders Nilsson, Johan Krause, Margrét Agnarsdóttir, Anders Sundin, Håkan Åhlström,

British Journal of Cancer

Abstract

AdCD40L therapy for MM was well tolerated. Local and distant responses along with better survival in the low-dose cyclophosphamide group are encouraging.

References

	Year	Citations

Page 1